Interesting update on Tim Ferriss – Lucid Dreaming, Quantum Gravity and Bioelectric Medicine | SRS #274. Curious how the grades will trend next quarter.
Interesting update on Tim Ferriss – Lucid Dreaming, Quantum Gravity and Bioelectric Medicine | SRS #274. Curious how the grades will trend next quarter.
Interesting update on Tim Ferriss – Lucid Dreaming, Quantum Gravity and Bioelectric Medicine | SRS #274. Curious how the grades will trend next quarter.
31 Comments
I like the balance sheet here—less leverage than peers.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Interesting update on Tim Ferriss – Lucid Dreaming, Quantum Gravity and Bioelectric Medicine | SRS #274. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Production mix shifting toward Videos might help margins if metals stay firm.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Interesting update on Tim Ferriss – Lucid Dreaming, Quantum Gravity and Bioelectric Medicine | SRS #274. Curious how the grades will trend next quarter.
Silver leverage is strong here; beta cuts both ways though.
Interesting update on Tim Ferriss – Lucid Dreaming, Quantum Gravity and Bioelectric Medicine | SRS #274. Curious how the grades will trend next quarter.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.